Cargando…

Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse

BACKGROUND: Endothelial dysfunction caused by increased oxidative stress is a critical initiator of macro- and micro-vascular disease development in diabetic patients. Ipragliflozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, offers a novel approach for the treatment of diabetes b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salim, Hotimah Masdan, Fukuda, Daiju, Yagi, Shusuke, Soeki, Takeshi, Shimabukuro, Michio, Sata, Masataka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080286/ https://www.ncbi.nlm.nih.gov/pubmed/27833913 http://dx.doi.org/10.3389/fcvm.2016.00043

Ejemplares similares

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
por: Rahadian, Arief, et al.
Publicado: (2020)

Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery
por: Maimaituxun, Gulinu, et al.
Publicado: (2017)

Deleterious Effects of Epicardial Adipose Tissue Volume on Global Longitudinal Strain in Patients With Preserved Left Ventricular Ejection Fraction
por: Maimaituxun, Gulinu, et al.
Publicado: (2021)

Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
por: Yagi, Shusuke, et al.
Publicado: (2015)

Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia
por: Nishimoto, Sachiko, et al.
Publicado: (2018)

Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice
por: Pham, Phuong Tran, et al.
Publicado: (2019)

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
por: Yagi, Shusuke, et al.
Publicado: (2017)

MicroRNA-378 Regulates Adiponectin Expression in Adipose Tissue: A New Plausible Mechanism
por: Ishida, Masayoshi, et al.
Publicado: (2014)

Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice
por: Matsumoto, Sachiko, et al.
Publicado: (2014)

n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease
por: Yagi, Shusuke, et al.
Publicado: (2017)

Pemafibrate, A Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Reduces Plasma Eicosanoid Levels and Ameliorates Endothelial Dysfunction in Diabetic Mice
por: Suto, Kumiko, et al.
Publicado: (2021)

Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice
por: Ganbaatar, Byambasuren, et al.
Publicado: (2021)

Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice
por: Shiota, Asuka, et al.
Publicado: (2012)

Expanding role of deoxyribonucleic acid-sensing mechanism in the development of lifestyle-related diseases
por: Nishimoto, Sachiko, et al.
Publicado: (2022)

Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease
por: Yagi, Shusuke, et al.
Publicado: (2014)

Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
por: Nishimoto, Sachiko, et al.
Publicado: (2016)

Plasma brain natriuretic peptide levels are elevated in patients with cancer
por: Bando, Sachiko, et al.
Publicado: (2017)

Erratum to: ‘Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome’
por: Yagi, Shusuke, et al.
Publicado: (2015)

Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome
por: Yagi, Shusuke, et al.
Publicado: (2015)

Clinical course and decision‐making in heart failure by preload stress echocardiography: a preliminary study
por: Kusunose, Kenya, et al.
Publicado: (2022)

Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension
por: Yagi, Shusuke, et al.
Publicado: (2015)

A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice
por: Munkhjargal, Uugantsetseg, et al.
Publicado: (2023)

Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects
por: Dagvasumberel, Munkhbaatar, et al.
Publicado: (2012)

Use of Echocardiography and Heart Failure In-Hospital Mortality from Registry Data in Japan
por: Kusunose, Kenya, et al.
Publicado: (2021)

Impact of cancer on short-term in-hospital mortality after primary acute myocardial infarction
por: Zheng, Robert, et al.
Publicado: (2021)

Clinical clerkship students’ preferences and satisfaction regarding online lectures during the COVID-19 pandemic
por: Yagi, Shusuke, et al.
Publicado: (2022)

Acute Hospital Mortality of Venous Thromboembolism in Patients With Cancer From Registry Data
por: Okushi, Yuichiro, et al.
Publicado: (2021)

Toll‐Like Receptor 9 Plays a Pivotal Role in Angiotensin II–Induced Atherosclerosis
por: Fukuda, Daiju, et al.
Publicado: (2019)

Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome
por: Yagi, Shusuke, et al.
Publicado: (2019)

Cardiac reserve by 6-minute walk stress echocardiography in systemic sclerosis
por: Arase, Miharu, et al.
Publicado: (2021)

Association between Vitamin D and Heart Failure Mortality in 10,974 Hospitalized Individuals
por: Kusunose, Kenya, et al.
Publicado: (2021)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
por: Kawabata, Yutaka, et al.
Publicado: (2020)

Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Evaluation of the input site and characteristics of the antegrade fast pathway based on three-dimensional bi-atrial stimulus-ventricle mapping
por: Matsumoto, Kazuhisa, et al.
Publicado: (2021)

Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor
por: Miyauchi, Masaaki, et al.
Publicado: (2017)

Levels of Adiponectin Expression in Peri-Renal and Subcutaneous Adipose Tissue and Its Determinants in Human Biopsied Samples
por: Maimaituxun, Gulinu, et al.
Publicado: (2020)

Frontiers of inflammatory disease research: inflammation in cardiovascular–cerebral diseases
por: Fukuda, Daiju, et al.
Publicado: (2021)

Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study
por: Kudo, Akihiro, et al.
Publicado: (2023)

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
por: Honda, Yasushi, et al.
Publicado: (2016)

Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date
por: Alkabbani, Wajd, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eof3mt0h644d0qo9l90lam8kmg